Clinical Trials Directory

Trials / Completed

CompletedNCT00161538

Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation

A Randomized, Prospective Multicenter Study to Examine the Optimal Position of the Atrial Leads for Therapy of the Sinus Node Syndrome

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
456 (planned)
Sponsor
Medtronic BRC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine which of 4 lead positions is most effective for pacemaker patients with Sick Sinus Syndrome in order to avoid development of atrial fibrillation.

Detailed description

The incidence of Atrial Fibrillation (AF) in Sick Sinus Syndrome patients treated with pacing is quite high. As AF can cause dizziness, fatigue, thromboembolism and ischemic stroke it is clinically relevant. Due to earlier publications pacing modes and lead placement seem to influence the incidence of AF. In this study the incidence of AF will be compared between 4 different atrial lead positions: 1. Free atrial wall 2. right atrial appendage 3. coronary sinus-os 4. Dual site right atrial pacing: b) plus c). The following primary parameters will be evaluated during the study period of 2 years after implantation: 1. Amounts of AF episodes with a duration of \> 48 hours 2. Amounts of AF episodes with a duration of \> 30 minutes 3. Consultations of physicians due to AF Secondarily, AF burden, Incidence of AF in total, Quality of Life, implant duration and complications will be evaluated.

Conditions

Interventions

TypeNameDescription
DEVICEPacing leads to be implanted according randomization.
DEVICESelection 9000 prevent AF an Diagnose AF

Timeline

Start date
2000-07-01
Completion
2006-06-01
First posted
2005-09-12
Last updated
2006-10-20

Locations

12 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT00161538. Inclusion in this directory is not an endorsement.